Role of resistin in diet-induced hepatic insulin resistance
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Resistin is an adipose-derived hormone postulated to link adiposity to insulin resistance.To determine whether resistin plays a causative role in the development of diet-induced insulin resistance, we lowered circulating resistin levels in mice by use of a specific antisense oligodeoxynucleotide (ASO) directed against resistin mRNA and assessed in vivo insulin action by the insulin-clamp technique.After 3 weeks on a high-fat (HF) diet, mice displayed severe insulin resistance associated with an approximately 80% increase in plasma resistin levels.In particular, the rate of endogenous glucose production (GP) increased more than twofold compared with that in mice fed a standard chow.Treatment with the resistin ASO for 1 week normalized the plasma resistin levels and completely reversed the hepatic insulin resistance.Importantly, in this group of mice, the acute infusion of purified recombinant mouse resistin, designed to acutely elevate the levels of circulating resistin up to those observed in the HF-fed mice, was sufficient to reconstitute hepatic insulin resistance.These results provide strong support for a physiological role of resistin in the development of hepatic insulin resistance in this model.Nonstandard abbreviations used: AMP-activated protein kinase (AMPK); antisense oligonucleotide (ASO); gluconeogenesis (GNG); glucose infusion rate (GIR); glucose-6-phosphatase (G6Pase); glycogen synthase kinase 3 (GSK3); high-fat (HF); intraperitoneal (i.p.); open reading frame (ORF); peroxisome proliferator-activated receptor-γ (PPAR-γ); phosphoenolpyruvate (PEP); phosphoenolpyruvate carboxykinase (PEPCK); rate of endogenous glucose production (GP); rate of glucose appearance (Ra); rate of glucose disappearance (Rd); standard chow (SC); triglyceride (TG); type 2 diabetes mellitus (DM2); uridinediphospho-glucose (UDP-glucose).Conflict of interest: S. Bhanot, B.P. Monia, and R.A. McKay are employees of ISIS Pharmaceuticals, which has an interest in developing antisense therapeutics to treat diabetes and other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Taken together with the emerging role of macrophages in the metabolic syndrome and in obesity (25, 35), these observations suggest that resistin may exert important metabolic functions in both rodents and humans,”
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 2×
“Because liver AMPK is required for the effects of adiponectin on plasma glucose levels (26), and its activation decreases G6Pase expression (27), we investigated whether changes in circulating resistin levels alter AMPK phosphorylation in the liver.”
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Self-citationObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Self-citationLeptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.
Halaas, J. L., Boozer, C., Blair-West, J., Fidahusein, N., Denton, D. A., & Friedman, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8878 · Cited by 1,033
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30
Combs, T. P., Berg, A. H., Obici, S., Scherer, P. E., & Rossetti, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14120 · Cited by 935
Self-citationResistin is expressed in human macrophages and directly regulated by PPARγ activators
Patel, L., Buckels, A. C., Kinghorn, I. J., Murdock, P. R., Holbrook, J. D., Plumpton, C., Macphee, C. H., & Smith, S. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02841-3 · Cited by 922
A family of tissue-specific resistin-like molecules
Steppan, C. M., Brown, E. J., Wright, C. M., Bhat, S., Banerjee, R. R., Dai, C. Y., Enders, G. H., Silberg, D. G., Wen, X., Wu, G. D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.502 · Cited by 637
Combs, T. P., Wagner, J. A., Berger, J., Doebber, T., Wang, W.-J., Zhang, B. B., Tanen, M., Berg, A. H., O’Rahilly, S., Savage, D. B., et al. (2002) · Endocrinology · doi:10.1210/endo.143.3.8662 · Cited by 565
Self-citationResistin and obesity-associated insulin resistance
Steppan, C. M., & Lazar, M. A. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00522-7 · Cited by 526
Rajala, M. W., Obici, S., Scherer, P. E., & Rossetti, L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16521 · Cited by 525
Self-citationLeptin-specific patterns of gene expression in white adipose tissue
Soukas, A., Cohen, P., Socci, N. D., & Friedman, J. M. (2000) · Genes & Development · doi:10.1101/gad.14.8.963 · Cited by 516
Serum Resistin (FIZZ3) Protein Is Increased in Obese Humans
Degawa-Yamauchi, M., Bovenkerk, J. E., Juliar, B. E., Watson, W., Kerr, K., Jones, R., Zhu, Q., & Considine, R. V. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021808 · Cited by 476
Mechanisms of Liver and Muscle Insulin Resistance Induced by Chronic High-Fat Feeding
Oakes, N. D., Cooney, G. J., Camilleri, S., Chisholm, D. J., & Kraegen, E. W. (1997) · Diabetes · doi:10.2337/diab.46.11.1768 · Cited by 414
Baker, B. F., Lot, S. S., Condon, T. P., Cheng-Flournoy, S., Lesnik, E. A., Sasmor, H. M., & Bennett, C. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.11994 · Cited by 371
Correlation between Serum Resistin Level and Adiposity in Obese Individuals
Azuma, K., Katsukawa, F., Oguchi, S., Murata, M., Yamazaki, H., Shimada, A., & Saruta, T. (2003) · Obesity Research · doi:10.1038/oby.2003.137 · Cited by 370
Overfeeding Rapidly Induces Leptin and Insulin Resistance
Wang, J., Obici, S., Morgan, K., Barzilai, N., Feng, Z., & Rossetti, L. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2786 · Cited by 355
Self-citationIncreased Resistin Gene and Protein Expression in Human Abdominal Adipose Tissue
McTernan, P. G., McTernan, C. L., Chetty, R., Jenner, K., Fisher, F. M., Lauer, M. N., Crocker, J., Barnett, A. H., & Kumar, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2407 · Cited by 350
Expression of ob Gene in Adipose Cells
Leroy, P., Dessolin, S., Villageois, P., Moon, B. C., Friedman, J. M., Ailhaud, G., & Dani, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2365 · Cited by 279
PPARγ and the Treatment of Insulin Resistance
OLEFSKY, J., & SALTIEL, A. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00306-4 · Cited by 279
Humoral Regulation of Resistin Expression in 3T3-L1 and Mouse Adipose Cells
Shojima, N., Sakoda, H., Ogihara, T., Fujishiro, M., Katagiri, H., Anai, M., Onishi, Y., Ono, H., Inukai, K., Abe, M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1737 · Cited by 207
Central Role of the Adipocyte in the Metabolic Syndrome
Bergman, R. N., Van Citters, G. W., Mittelman, S. D., Dea, M. K., Hamilton-Wessler, M., Kim, S. P., & Ellmerer, M. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.34108 · Cited by 202
Obesity, diabetes and the central nervous system
Porte Jr., D., Seeley, R. J., Woods, S. C., Baskin, D. G., Figlewicz, D. P., & Schwartz, M. W. (1998) · Diabetologia · doi:10.1007/s001250051002 · Cited by 186
Sindelar, D. K., Chu, C. A., Rohlie, M., Neal, D. W., Swift, L. L., & Cherrington, A. D. (1997) · Diabetes · doi:10.2337/diab.46.2.187 · Cited by 170
Rajala, M. W., Lin, Y., Ranalletta, M., Yang, X. M., Qian, H., Gingerich, R., Barzilai, N., & Scherer, P. E. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0048 · Cited by 153
Self-citationMechanisms Regulating Adipocyte Expression of Resistin
Hartman, H. B., Hu, X., Tyler, K. X., Dalal, C. K., & Lazar, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201451200 · Cited by 145
Combs, T. P. (2002) · Endocrinology · doi:10.1210/en.143.3.998 · Cited by 125
Rossetti, L., Stenbit, A. E., Chen, W., Hu, M., Barzilai, N., Katz, E. B., & Charron, M. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119711 · Cited by 93
Self-citationBarthel, A. (2002) · Endocrinology · doi:10.1210/en.143.8.3183 · Cited by 76
Resistin is regulated by C/EBPs, PPARs, and signal-transducing molecules
Song, H., Shojima, N., Sakoda, H., Ogihara, T., Fujishiro, M., Katagiri, H., Anai, M., Onishi, Y., Ono, H., Inukai, K., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02551-2 · Cited by 67
Kopelman, P. G., & Hitman, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90267-7 · Cited by 66
Glutathione modulates rat and mouse hepatocyte sensitivity to tumor necrosis factor α toxicity
Xu, Y., JONES, B., Neufeld, D. S., & Czaja, M. J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70095-2 · Cited by 63
Loss of hepatic autoregulation after carbohydrate overfeeding in normal man.
Clore, J. N., Helm, S. T., & Blackard, W. G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118243 · Cited by 45
Pg, K., & Ga, H. (1998) · PubMed · Cited by 36
Cited by
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
“Resistin decreases AMPK phosphorylation (Banerjee et al., 2004; Muse et al., 2004) in liver.”
BackgroundAdipose tissue as an endocrine organ
Galic, S., Oakhill, J. S., & Steinberg, G. R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.018 · Cited by 1,562
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110062 · Cited by 831
Metadata
- Authors
- Muse, E. D., Obici, S., Bhanot, S., Monia, B. P., McKay, R. A., Rajala, M. W., Scherer, P. E., & Rossetti, L.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-07-15
- Volume
- 114
- Issue
- 2
- Pages
- 232-239
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1979101494
- Cited by
- 372
- References
- 40
- FWCI
- 21.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.